Laxmi Organic Industries Limited (LXCHEM.BO)
INR 252.6
(0.0%)
INR 252.6
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 28.65 Billion | 27.87 Billion | 30.79 Billion | 17.59 Billion | 15.26 Billion | 15.59 Billion |
| Cost of Revenue | 24.07 Billion | 19.06 Billion | 21.67 Billion | 12.16 Billion | 11.27 Billion | 11.2 Billion |
| Gross Profit | 4.57 Billion | 8.8 Billion | 9.12 Billion | 5.43 Billion | 3.99 Billion | 4.39 Billion |
| Operating Expenses | 3.07 Billion | 6.96 Billion | 5.8 Billion | 3.64 Billion | 3.27 Billion | 3.17 Billion |
| Selling, General and Administrative Expenses | 3.07 Billion | 1.39 Billion | 1.17 Billion | 540.22 Million | 442.71 Million | 475.72 Million |
| Research and Development Expenses | - | 121.54 Million | 97.8 Million | 85.86 Million | 58.39 Million | 18.99 Million |
| Other Expenses | - | 8.15 Million | 27.23 Million | 500 Thousand | 8.61 Million | 23.82 Million |
| Cost and Expenses | 27.15 Billion | 26.03 Billion | 27.47 Billion | 15.8 Billion | 14.54 Billion | 14.37 Billion |
| Operating Income | 1.49 Billion | 1.83 Billion | 3.32 Billion | 1.77 Billion | 652.12 Million | 1.15 Billion |
| Interest Expense | 90.17 Million | 110.25 Million | 128.9 Million | 149.45 Million | 125.2 Million | 161.04 Million |
| Income Tax Expense | 502.6 Million | 483.01 Million | 614.39 Million | 313.47 Million | 105.62 Million | 251.98 Million |
| Earnings before Tax | 1.7 Billion | 1.72 Billion | 3.18 Billion | 1.58 Billion | 808.01 Million | 975.89 Million |
| Net Income | 1.2 Billion | 1.24 Billion | 2.57 Billion | 1.27 Billion | 701.02 Million | 723.91 Million |
| Earnings Per Share Basic | 4.46 | 4.70 | 9.76 | 5.59 | 2.86 | 2.75 |
| Earnings Per Share Diluted | 4.43 | 4.67 | 9.62 | 5.58 | 2.86 | 2.75 |
| Weighted Average Shares Outstanding | 270.25 Million | 264.98 Million | 263.66 Million | 227.08 Million | 244.71 Million | 263.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 272.17 Million | 266.93 Million | 267.38 Million | 227.8 Million | 244.71 Million | 263.66 Million |
| Gross Margin | 0.16 | 0.32 | 0.30 | 0.31 | 0.26 | 0.28 |
| EBIT Margin | 0.10 | 0.09 | 0.12 | 0.13 | 0.08 | 0.10 |
| Profit Margin | 0.04 | 0.04 | 0.08 | 0.07 | 0.05 | 0.05 |
| EBITDA | 2.86 Billion | 2.59 Billion | 3.77 Billion | 2.22 Billion | 1.46 Billion | 1.61 Billion |
| Earnings Before Tax Margin | 0.05 | 0.07 | 0.11 | 0.10 | 0.04 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.71 Billion | 7.18 Billion | 28.65 Billion | 7.92 Billion | 6.94 Billion | 6.52 Billion |
| Cost of Revenue | 4.94 Billion | 5.87 Billion | 24.07 Billion | 6.32 Billion | 4.81 Billion | 4.61 Billion |
| Gross Profit | 2.76 Billion | 1.3 Billion | 4.57 Billion | 1.6 Billion | 2.13 Billion | 1.9 Billion |
| Operating Expenses | 2.29 Billion | 855.8 Million | 3.07 Billion | 1 Billion | 1.88 Billion | 1.79 Billion |
| Selling, General and Administrative Expenses | 1.01 Billion | 855.8 Million | - | 1 Billion | 663.47 Million | 650.83 Million |
| Research and Development Expenses | - | - | - | 165.12 Million | - | - |
| Other Expenses | 2.29 Billion | 119.76 Million | 282.29 Million | 107.3 Million | 53.4 Million | 82.06 Million |
| Cost and Expenses | 7.24 Billion | 6.72 Billion | 27.15 Billion | 7.32 Billion | 6.69 Billion | 6.4 Billion |
| Operating Income | 472.32 Million | 453.24 Million | 1.49 Billion | 594.57 Million | 247.31 Million | 113.83 Million |
| Interest Expense | 76.37 Million | 33.18 Million | 65.48 Million | -6.32 Million | 5.2 Million | 20.61 Million |
| Income Tax Expense | 181.61 Million | 196.31 Million | 502.6 Million | 236.81 Million | 23.62 Million | 68.15 Million |
| Earnings before Tax | 462.48 Million | 539.82 Million | 1.7 Billion | 679.86 Million | 295.51 Million | 175.28 Million |
| Net Income | 280.87 Million | 343.51 Million | 1.2 Billion | 443.04 Million | 271.89 Million | 107.13 Million |
| Earnings Per Share Basic | 1.01 | 1.24 | - | 1.62 | 0.99 | 0.40 |
| Earnings Per Share Diluted | 1.00 | 1.23 | - | 1.62 | 0.97 | 0.40 |
| Weighted Average Shares Outstanding | 278.08 Million | 276.45 Million | 270.25 Million | 273.48 Million | 274.63 Million | 265.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 280.87 Million | 279.27 Million | 272.08 Million | 273.48 Million | 280.29 Million | 267.82 Million |
| Gross Margin | 0.36 | 0.18 | 0.16 | 0.20 | 0.31 | 0.29 |
| EBIT Margin | 0.11 | 0.10 | - | 0.11 | 0.08 | 0.07 |
| Profit Margin | 0.04 | 0.05 | 0.04 | 0.06 | 0.04 | 0.02 |
| EBITDA | 813.41 Million | 711.96 Million | - | 900.1 Million | 576.01 Million | 471.38 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.05 | 0.08 | 0.04 | 0.02 |
RXMD
MOREPENLAB
GBLX
MAXHEALTH
PHVS
TI